Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

2022 Support Group Leader Training and Celebration

You’re Invited!

Supporting the Support Group Leader Weekend 

Training and Celebration for ZERO/Us TOO Support Groups

August 12 – 13, 2022 – Chicago, IL

You are invited to join us for an IN-PERSON Support Group Leader training and celebration of more than 30 years of Us TOO Support Groups! We will also be celebrating YOU – and all the amazing work you do while providing support to prostate cancer patients and their loved ones year after year.

Friday, August 12th will kick-off with an evening celebration of Us TOO’s history and new beginnings with ZERO. The weekend will continue on Saturday with SGL training sessions to help you access information and best practices for leading successful support groups. After lunch, you will have the opportunity to learn from some of the top experts in the prostate cancer community. 

Your RSVP is required by June 15, 2022.


Who Should Attend?

All are welcome to the Friday evening celebration and reception, but an RSVP is required by all planning to attend. SGLs, spouses, and partners are all welcome as we celebrate and mingle with one another, with ZERO Staff, and with our generous sponsors.

Saturday’s SGL training is specifically for Us TOO Support Group Leaders. All-day attendance is required. The training sessions will be recorded and made available approximately 3 weeks after the event.


Friday, August 12

  • 3:00 – 4:00 pm – Check-in 
  • 4:00 – 4:30 pm – Welcome & Celebration
  • 4:30 – 6:00 pm –  Live Music, Networking, Cash Bar and Passed Appetizers

Friday dinner will not be provided, but several restaurants and shops are located within walking distance of the hotel.

Saturday, August 13

  • 8:00 am – 9:00 am – Check-In,Visit Sponsor Tables, Breakfast
  • 9:00 am – 9:05 am – Welcome – Terri Likowski, ZERO
  • 9:05 am – 10:20 am – Communications Essentials for Support Group Leaders – Michael Capaldi
  • 10:20 am – 10:30 am – Break
  • 10:30 am – 11:45 am – Panel Discussion Look How Far We’ve Come the Last 30+ Years in the Prostate Cancer World – Early Diagnosis, Screening and Imaging, Metastatic Disease, Health Equity – Dr. Alicia Morgans, Dr. Adam Murphy, and Dr. Brian Helfand
  • 11:45 am – 12:00 pm – Zero Updates – Terri Likowski and Shelby Moneer, ZERO
  • 12:00 pm – 1:00 pm – Lunch and Sponsor Speaker – Sue Hensley, Pfizer
  • 1:00 pm – 2:15 pm – Educational Empowerment – Dr. Mark Moyad
  • 2:15 pm – 3:15 pm – The Day-to-Day: Quality of Life After Treatment – Sara Sattler
  • 3:15 pm – 3:30 pm – Break and Snack
  • 3:30 pm – 4:30 pm – Panel Discussion Advanced Imaging and Theranostics – Dr. Michael Quast and Dr. Benjamin Maughan
  • 4:30 pm – 4:45 pm – Closing Remarks – Terri and Shelby

Saturday dinner is on your own. As a reminder, there are restaurants and shops that are located within walking distance of the hotel.


Aloft Chicago O’Hare
9700 Balmoral Avenue
Rosemont, IL 60018

Hotel Check-in: 3:00 p.m.

ZERO will cover the costs for Friday and Saturday hotel rooms, but you must make your hotel reservation using the link below.  You will be asked for a credit card for incidentals, but you will not be charged for your room. You are responsible for making your hotel reservation. 

The deadline for reserving a room in this room block is July 21, 2022. Hotel space is limited.



Transportation costs are not covered. For support groups who have funds in their accounts, this is an approved expense to use to cover travel costs for leaders and co-leaders. 

If flying, we recommend flying into Chicago O’Hare Airport no later than 2:30 p.m. CT on Friday to be on time for check-in and the reception. Aloft Chicago O’Hare is NOT close to Midway Airport. A free shuttle is available from O’Hare Airport to Aloft – please follow signs at the airport upon arrival for shuttle information.

What should I wear?

Business casual is recommended for both days. However, please feel free to wear blue on Friday and dress comfortable for Saturday’s all-day training session. You may want to bring and wear your ZERO/Us TOO zip-up on Saturday. If you have not received one, we will have one ready for you at check-in. 

Which meals will be provided?

  • Friday: One drink ticket and appetizers will be provided on Friday for ALL attendees.
  • Saturday: A heart and prostate healthy breakfast and lunch will be provided on Saturday for Support Group Leaders ONLY. 

The hotel is walking distance to many stores and restaurants.

Meet the Speakers!

Michael Capaldi is Owner, Versatile Collaboration LLC, a strategic consulting firm, and the Leading-EDGE Coaching & Performance practice focused primarily in the life sciences sector. He is also a Senior Advisor for Penn Quarter Partners, a public affairs firm based in Washington D.C. where he consults with clients across the biopharmaceutical and medical device industries. Lastly, he is the Executive Director for the Institute for Gene Therapies, a nonprofit coalition established in 2020. Prior to these roles Mike had a 22-year career at Sanofi where among other duties he led Sanofi’s Training function; responsible for the development of over 10,000 US employees. 

Dr. Brian Helfand is the Richard Melman and Ron Chez family chair and Chief of the Division of Urology at NorthShore University Healthsystem in Evanston, Illinois. He is a Clinical Professor at the University of Chicago and former Adjunct Professor at Northwestern University. He holds a dual MD, PHD degrees and is head of a clinical and research programs focused on prostate cancer. Dr. Helfand has authored more than 200 peer reviewed manuscripts. He has been involved in many clinical trials studying interventions, biomarkers and imaging technologies for men with early and late stage prostate cancer. Currently, his clinical and research interests are devoted towards using novel imaging techniques and biomarkers, including genetic tests, to help guide clinical decision making for men with newly diagnosed and advanced prostate cancer.

Benjamin Maughan MD, PharmD is an Assistant Professor in the Division of Medical Oncology at Huntsman Cancer Institute specializing in genitourinary malignancies. He has been focused on studying resistance mechanisms to identify predictive biomarkers for systemic therapy as well as identifying novel treatments for all genitourinary cancers. For instance in metastatic prostate cancer he has been studying the role of resistance pathways including expression of truncated androgen receptors (ex. AR-V7 expression) and loss of tumor suppressors such as PTEN and Rb. Regarding novel treatment development he is the principle investigator for a number of investigator initiated clinical trials as well as the national lead investigator for SWOG 2200 testing a novel immune therapy combination in papillary renal cell carcinoma.

Dr. Alicia Morgans is a Genitourinary Medical Oncologist and the Medical Director of the Survivorship Program at Dana-Farber Cancer Institute in Boston, Massachusetts. She specializes in investigating complications of systemic therapy for prostate cancer survivors, including the study of skeletal, cardiovascular, diabetic, and cognitive complications, and in investigating and incorporating shared decision making into the treatment process for men with advanced prostate cancer.

Dr. Morgans’ research focus is on improving care and patient outcomes in advanced prostate cancer. Her research investigates the side effects of cancer treatment (including the prevention, diagnosis of, and treatment of these effects) and treatment decision-making among men with advanced prostate cancer. She also serves as Vice Chair of ZERO’s Board of Directors and has contributed to numerous educational resources on behalf of ZERO. 

Dr. Mark A. Moyad of University of Michigan Medical Center, Department of Urology is an expert on the power of lifestyle changes, supplements, and other over the counter (OTC) options to improve overall mental, physical, and spiritual wellness.



Dr. Adam Murphy is an African American urologist who focuses half of his efforts on prostate cancer disparities research. He has conducted several multi-institutional, multidisciplinary, and community engaged research protocols and has established himself as a translational health disparities researcher and biomarker expert in clinically localized prostate cancer.

Dr. Murphy received both his MD and MBA from the University of Chicago and his MS from Northwestern University. He completed his residency in Urology at Northwestern University and is currently affiliated with Northwestern University, Jesse Brown VA Medical Center, and John H. Stroger Cook County Hospital.

Sara Sattler is an international speaker specializing in urology and men’s sexual health, education, and therapy, post prostate cancer recovery, ED (erectile dysfunction), therapy options and treatments. An international prostate cancer support network guest speaker, Ms. Sattler has dedicated her career to the health and wellness sector, moving specifically to men’s health. She works directly with patients and their partners who are experiencing the effects of erectile dysfunction and incontinence, either of an organic nature or post-operative. She provides a safe, educational, and often humorous space for men to talk candidly about their challenges after prostate cancer treatment. 


Premier Sponsors:

Royal Blue Event Sponsors:

Sapphire Blue Event Sponsors: